Next Article in Journal
Pimarane Diterpenes from Fungi
Previous Article in Journal
Exploring Novel Pyridine Carboxamide Derivatives as Urease Inhibitors: Synthesis, Molecular Docking, Kinetic Studies and ADME Profile
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 15
Issue 10
10.3390/ph15101289
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Chromatographic Techniques and Pharmacological Analysis as a Quality Control Strategy for Serjania triquetra a Traditional Medicinal Plant

by
A. Berenice Aguilar-Guadarrama
1,
Guadalupe Yáñez-Ibarra
2,
Martha Edith Cancino-Marentes
3,
Paola González-Ibarra
4,
Rolffy Ortiz-Andrade
5,
Amanda Sánchez-Recillas
5,
Javier-German Rodríguez-Carpena
2,
Yoshajandith Aguirre-Vidal
6,
Irma-Martha Medina-Diaz
7 and
Gabriela Ávila-Villarreal
2,8,*
1
Centro de Investigaciones Químicas, IICBA, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Col. Chamilpa, Cuernavaca 62209, Mexico
2
Centro Nayarita de Innovación y Transferencia de Tecnología A. C. “Unidad Especializada en I+D+i en Calidad de Alimentos y Productos Naturales”, Universidad Autónoma de Nayarit, Tepic 63000, Mexico
3
Unidad Académica de Medicina Humana, Universidad Autónoma de Nayarit, Tepic 63000, Mexico
4
Unidad Académica de Salud Integral, Universidad Autónoma de Nayarit, Tepic 63000, Mexico
5
Laboratorio de Farmacología, Facultad de Química, Universidad Autónoma de Yucatán, Mérida 97069, Mexico
6
Red de Estudios Moleculares Avanzados, Campus III, Instituto de Ecología A.C. (INECOL), Xalapa 91073, Mexico
7
Laboratorio de Contaminación y Toxicología Ambiental, Secretaría de Investigación y Posgrado, Universidad Autónoma de Nayarit, Tepict 63000, Mexico
8
Unidad Académica de Ciencias Químico Biológicas y Farmacéuticas, Universidad Autónoma de Nayarit, Tepic 63000, Mexico
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2022, 15(10), 1289; https://doi.org/10.3390/ph15101289
Submission received: 25 August 2022 / Revised: 6 October 2022 / Accepted: 11 October 2022 / Published: 20 October 2022
(This article belongs to the Section Natural Products)
Browse Figures
Review Reports Versions Notes

Abstract

:
Serjania triquetra is a medicinal plant widely used in traditional medicine for the treatment of urinary tract diseases, renal affections, and its complications. The population can buy this plant in folk markets as a raw material mixed with several herbal remedies or as a health supplement. On the market, two commercial presentations were found for the vegetal material; one had a bulk appearance and the other was marketed wrapped in cellophane bags (HESt-2, HESt-3). Nevertheless, the plant has not been exhaustively investigated and quality control techniques have not been developed. This research aimed to realize a phytochemical study using an authentic, freshly collected sample as a reference for S. triquetra (HESt-1), using the compounds identified. A method for the determination of preliminary chromatographic fingerprinting was developed. Additionally, the vasorelaxant effect from three samples was evaluated with ex vivo rat models. Thus, three hydroalcoholic extracts (HESt-1, HESt-2, and HESt-3) were prepared by maceration. A total of nine compounds were fully identified from HESt-1 after the extract was subjected to open-column chromatography. Seven metabolites were detected by gas chromatography, while ursolic acid (UA) and allantoin were isolated and identified using UPLC-MS and NMR, respectively. Three extracts were analyzed for their chromatographic fingerprint by UPLC-MS. Biological activity was explored by ex vivo rat aorta ring model to evaluate vasorelaxant activity. All extracts showed a vasorelaxant effect in a concentration-dependent and endothelium-dependent manner. S. triquetra vascular activity may be attributed to UA and allantoin compounds previously described in the literature for this activity.

1. Introduction

Hypertension is a multifactorial disease and is a major public health problem due to its high prevalence all around the world. Around 12.8% of the overall of all annual deaths globally arise because of high blood pressure. It is predicted to increase to 1.56 billion adults with hypertension by 2025 and is the most common risk factor leading to hypertensive cardiovascular disease, heart failure, atherosclerotic complications including stroke, coronary heart disease, renal insufficiency, and hypertensive renal disease [1,2]. In this context, these complications and elevated blood pressure are pervasive findings in patients with chronic kidney diseases (CKD). The kidney plays a significant regulatory role in many aspects of blood pressure, particularly in the presence of comorbidities such as diabetes and prevalent cardiovascular disease, contributing greatly to hypertension development as a secondary condition [3]. When kidney function is compromised, the ability of the kidney to maintain balance and blood pressure might be reduced. The main problem for treating elevated blood pressure is due to a silent asymptomatic phase leading to an untreated or uncontrolled stage for most individuals [4].
Herbal medicinal preparations have been used since ancient times as medicines for the treatment of a range of diseases. Increasing worldwide demand for herbal medicinal products requires extensive research, including information about the phytochemical composition related to their clinical curative effects [5,6].
Undoubtedly traditional medicine plays an important role in improving and maintaining health, and for many cultures, it is a fundamental part of their heritage [7,8]. In Mexico, plants are an important element of traditional medicine, and many of them are considered part of the Mexican cultural heritage. Currently, the number of plant species used in Mexico with medicinal attributes varies from 4000 to 6000; however, there are numerous concerns related to the use of herbal medicines because, unlike conventional medications, they are not fully regulated, and most of these species have not been subjected to chemical, toxicological, pharmacological, or clinical investigations [9,10,11,12,13].
Serjania triquetra Radlk. (Sapindaceae) is a popular plant used in folk medicine. The Serjania genus is native to the neotropics realm: S. triquetra is a climbing plant formed by brown bark lianas, commonly known as “Palo de tres costillas”, and is distributed in Mexico and Central America. In Mexican traditional medicine, the aerial parts are used to treat hepatitis, urinary inflammation, infection, kidney stones, kidney diseases, and their complications. S. triquetra has been turned into a popular remedy and it can be found in folk markets in its raw form, mixed with several herbal medicine remedies, or as a health supplement. Its e-commerce is also increasing [14,15]. Some pharmacological activities previously reported for Serjania genus are anticancer, analgesic, antibacterial, antioxidant, and anti-inflammatory, among others. Some of the compounds that have been identified for this genus are flavonoids, terpenes, steroids, tannins, alkaloids, and saponins [14].
Previous phytochemical studies of the aerial parts have identified stigmasterol, oleanolic acid, morolic acid, hederagenin, and 11α-hidroperoxy-hederagenin [16], with a wide range of pharmacological properties reported for these compounds. However, there is no evidence of exhaustive experimental studies that can demonstrate any of its pharmacological effects [15].
Herbal material is usually a complex phytochemical mixture, thus, identifying its active compounds and their standardization is not an easy task [17]. Usually, the biological activity of medicinal plants cannot be attributed to a single active principle but results from a synergistic interplay of its constituents. Consequently, quality control for fresh or finished herbal preparations is required, either based on phytochemical markers constituents, or its analytical fingerprints, correlated to its pharmacological activity, making it challenging to develop quality control techniques [18].
This research aimed to characterize the phytochemical profile, initially using chromatographic fingerprinting, and to evaluate the vasorelaxant effect of S. triquetra in ex vivo rat models.
Major compound isolation led to the identification of nine compounds; ursolic acid (UA) and allantoin were isolated and identified by spectrometric techniques. According to our findings, this plant is rich in UA, a pentacyclic triterpenoid well known for its wide-ranging pharmacological activities.
Three hydroalcoholic extracts were prepared by maceration. S. triquetra (HESt-1) was an authentic, freshly collected sample and was used as a reference material, HESt-1, which was compared with two commercial samples (HESt-2, HESt3). Reference extract HESt-1 was subjected to open-column chromatography for major compound isolation, and nine compounds were fully identified; UA and allantoin were isolated and identified using UPLC-MS and NMR, respectively. Additionally, seven compounds were detected by gas chromatography in non-polar fractions. Elevated blood pressure is a lingering finding in patients with kidney diseases. According to our findings, this plant is rich in UA, a pentacyclic triterpenoid well known for its wide-ranging pharmacological activities [19]. UA showed antioxidant, diuretic, natriuretic, and saluretic activity in hypertension and hemodynamic in in vivo models, according to Somova in 2003 [20]. Furthermore, allantoin, a natural imidazol that is present in the extracts, is reported to elicit agonist activity in imidazoline I-1 receptor (I-1R), and I1 receptors partially mediate the central hypotensive effects of clonidine-like drugs [21]. With these previous findings, we decided to evaluate the extracts using an ex vivo rat aorta ring model to predict biological activity linked to the vasorelaxant effect.

2. Results

2.1. Extract Preparation and Thin Layer Chromatography (TLC) Comparision for Collected and Comercials Samples of Serjania triquetra

Three extracts were prepared by maceration, and the results are presented in Table 1. Extracts were initially compared by TLC (Supplementary Material Figure S1) and no differences were observed between the extracts.

2.2. Chemical Composition of Authentic Serjania triquetra Sample

With the intention of developing a standard analytical method to compare commercial products, the chemical characterization of an authentic sample (HESt-1) was performed. HESt-1 was used to compare commercial samples by chromatographic techniques. The reference extract HESt-1 was subjected to open-column chromatography (OCC) for major compound isolation. As a result of OCC, 121 fractions were collected and pooled into 9 groups by chromatographic similarity and analyzed separately. As a result of the chemical analysis, a total of nine compounds were identified. UA and allantoin were isolated and identified using UPLC-MS and NMR, respectively. Additionally, seven compounds were detected by gas chromatography from non-polar fractions.
Compound 1 was obtained as a white powder with a yield of 0.52% from the fraction eluted with ethyl acetate-methanol in a ratio of 8:2 from Rn10 in OCC. The precipitate was insoluble in methanol, and the presence of a single compound was observed using TLC. Thus, NMR experiments were obtained, and the list of experimental chemical shifts is shown in Table 2. The analysis of data obtained from the experiments in 1D (1H NMR and 13C NMR), shows that this compound corresponds to (2,5-dioxoimidazolidin-4-yl) urea, commonly known as allantoin. This was confirmed with spectroscopy literature data, as shown by Rasheed et al. [22].
Moreover, Rn11-12 in OCC resulted in the presence of a second compound. The compound was a powder which was soluble in methanol, identified as UA (IUPAC name (1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid). Elution in TLC showed the characteristic purple coloration of the pentacyclic triterpenes. The result was compared with an authentic standard sample of UA using TLC. Both samples had a similar retention factor, and the presence of UA was corroborated by ultra-performance liquid chromatography coupled with mass spectrometry (UPLC-MS) using a selected ion recording experiment (SIR), where [M-H]− 455.72 and 455.38 Da was found in the authentic UA and the sample, respectively.
Additionally, seven compounds (Figure 1) from the non-polar fractions (groups Rn01-Rn05) of the EHASt-1 were identified using gas chromatography coupled with mass spectrometry (GC-MS). The five compounds eluted in 100% dichloromethane fractions (Rn01, compounds 3–7, 0.15%) and two compounds in the fractions eluted with dichloromethane-ethyl acetate in a ratio of 7:3 (Rn05, compounds 8 and 9, 0.54%). Table 3 shows the chemical composition and the content in the percentage of compounds analyzed by GC-MS in the non-polar fractions. After GC-MS identification, these compounds were further confirmed using targeted UPLC-MS in SIR mode.

2.3. Comparison of Authentic and Commercial Botanical Samples: Botanical Reference Fingerprint Development by UPLC-MS as Quality Control Suggested Technique

A UPLC-ESI-MS method was developed with the purpose of creating a rapid and easy quality control technique for S. triquetra samples. For each hydroalcoholic sample extract, both authentic (HESt-1) and commercial samples (HESt-2, HESt3), a full mass scan and a targeted SIR experiment were conducted. For each SIR experiment, nine different channels were selected, one channel for each mass of the nine identified compounds. The results are shown in Figure 2. The signal intensity in samples HESt-1, HESt-2, and HESt-3 is different, where the fresh plant HESt-1 provided the highest intensity compared to HESt-2 and HESt-3. Figure 2 shows the variation of signal intensities for the three herbal samples prepared by the same conditions and analyzed in the same UPLC-MS method, as indicated in the total ion chromatogram and the SIR experiment for each compound. These differences in signal intensity between the samples could infer the storage condition of the herbal materials. For the herbal material, bulk-marketed HESt-2 and cellophane-marketed HESt-3 in Figure 2A, we can observe that the lowest signal intensity was for the bulk-marketed samples (HESt-2) compared to the freshly collected material. Also, we can discern that herbal material cellophane preserve shows a major intensity of signals than bulk marketed material but lower than freshly collected material. These findings support the importance of good agricultural and commercialization practices for herbal medicinal products.

2.4. Pharmacological Evaluation (Ex Vivo Model)

Evaluation of all HESt extracts by ex vivo model has shown that it produces a vasorelaxant effect in aortic rings pre-contracted by noradrenaline. In this study, it was found to induce a significant relaxant effect in a concentration-dependent and endothelium-dependent manner (Figure 3). All extracts from S. triquetra were more potent and less efficient than carbachol and less potent and efficient than nifedipine, both used as positive controls in the presence and absence of endothelium, respectively.

3. Discussion

The increasing requirement for herbal medicines certainly leads to providing quality controls for herbal raw materials. Standardization relating to herbal drugs arises from the complex composition of traditional medicine that is used in the form of whole plants or plant parts [7]. With the objective of assuring the reproducible quality control methods of any herbal remedy, the proper collection and identification of the authentic herbal material are essential; in addition to this, performing phytochemical studies to develop these quality control strategies is crucial in the process. Developing quality control strategies for herbal remedies from the starting material needs to consider several factors. For this project, we linked the phytochemical study with an ex vivo model, indicating the potential activity in all samples, as shown in Figure 3, when UA and allantoin are present, the vasorelaxant effect is preserved in the three extracts [18,21]. Furthermore, preliminary chromatographic fingerprinting was developed by ultra-performance liquid chromatography coupled with mass spectrometry as a quality control approach.
Persistent elevated blood pressure can potentially lead to kidney damage and is a lingering finding in patients with kidney diseases. According to our findings, S. triquetra is rich in UA, a pentacyclic triterpenoid well known for its wide-ranging pharmacological activities. UA showed antioxidant, diuretic, natriuretic, and saluretic activity in hypertension and hemodynamic in vivo models, according to Somova in 2003 [20]. Furthermore, allantoin, a natural imidazol that is present in the extracts, is reported to elicit agonist activity in imidazoline I-1 receptor (I-1R), while I1 receptors partially mediate the central hypotensive effects of clonidine-like drugs. With these previous findings, we decided to evaluate the extracts using an ex vivo rat aorta ring model to predict biological activity linked to the vasorelaxant effect. As shown in Figure 3, the vasorelaxant effect is preserved in the three extracts [21].
Thus, we hypothesize that all these named compounds in S. triquetra extracts effects contributed to a reduction in peripheral vascular resistance, leading to a significant hypotensive effect. These results are novel for S. triquetra.

4. Materials and Methods

4.1. Plant Material

For the development of a reference, stems of S. triquetra were collected in Santiago Ixcuintla, Nayarit, Mexico, on 21 November 2017 (GPS coordinates: 104°59′47.1″ W, 21°44′27.0″ N). The botanical identification was made by Ana María Hanan Alipi (Universidad Autónoma de Nayarit), and the voucher specimen was deposited in the Herbarium of the Universidad Autónoma de Nayarit, Tepic, Nayarit (Herbarium UAN 1751). Additionally, two samples were purchased commercially in two different presentations, one in bulk form to prepare HESt-2 and the other in cellophane bags to prepare HESt-3 extracts.

4.2. Extract Preparation, Extraction, and Isolation

Three hydroalcoholic extracts were prepared by maceration. An authentic freshly collected sample was used as a reference for S. triquetra (HESt-1) and was compared with two commercial samples (HESt-2, HESt-3). Reference extract HESt-1 was subjected to open-column chromatography.
The dry stems were pulverized using a mill (Romer mill series II®, model 4679737, Union, MO, USA). The milled sample was extracted with a hydroalcoholic solution (85%) for 72 h at room temperature after extraction and filtered using filter paper Whatman No. 1 (WhatmanTM, Cat No. 1001.110, Maidstone, UK). The solvent extract was removed by a rotary evaporator (Buchi®, Gwangmyeong, Korea), as established in the General Method of Analysis MGA-FH 0070, extractable material of the Herbal Pharmacopoeia of the United Mexican States [15]. For extract preparation, 850 g was used for HESt-1, 500 g for HESt-2, and 210 g for HESt-3.
For chromatographic fractionation, 8 g of the complete extract from authentic fresh collected plant (HESt-1) was subjected to OCC in which the silica gel 60 (0.063–0.200 mm Mesh) was packed in a glass column (45 mm × 500 mm), using a dichloromethane–ethyl acetate–methanol–water elution gradient system and mixes of these solvents. Eluted fractions were monitored by thin-layer chromatography using aluminum sheets of TLC silica gel 60 F254.

4.3. Nuclear Resonance Magnetic (NMR)

A Varian Mercury 200 equipment at 200 and 50 MHz frequencies were used to obtain the 1H and 13C experiments, respectively. Samples were dissolved in deuterated dimethyl sulfoxide-d6 (DMSO-d6) and TMS as reference obtained from Sigma-Aldrich (St. Louis, MO, USA).

4.4. Development of Quality Control Methodology by Fingerprinting Analysis Using Ultra-Performance Liquid Chromatography Coupled with Mass Spectrometry (UPLC-MS)

Chromatographic separation was performed using ACQUITY UPLC H-Class Bio System (Waters Corp., Milford, MA, USA). The separation was conducted using an ACQUITY UPLC® HSS T3 130 Å column (1.8 µm, 2.1 mm × 50 mm, Waters®, Milford, MA, USA), column temperature 35 °C with an isocratic elution of 20% A to 80% B in 10 min using a binary system consisting of ammonium hydroxide (0.05%) in water (A) and acetonitrile (B). 3 μL of the samples at 100 ppm concentration were injected with a flow rate of 0.4 mL/min; acetonitrile was used as a blank solvent.
Detection was performed using ACQUITY QDa detector mass spectrometer (Waters Corp., Milford, MA, USA) with an electrospray ionization interface (ESI); the voltage of the capillary was set to −2 kV for the negative ion mode (ESI-). The data was processed using Waters Empower™ 3 software (Waters Corp., Milford, MA, USA). A Mass scan acquisition was programmed at 50 to 1250 Da, and SIR for each known mass was selected.

4.5. Gas Chromatography Coupled with Mass Spectrometry (GC-MS)

An Agilent plus equipment coupled to a mass detector (Agilent 5379N 30-5550; electron impact ionization mode at 70 eV) with an HP5-MS capillary column (30 m × 0.225 mm × 0.25 μm) was used to acquire the gas chromatography–mass spectrometry (GC–MS) experiments. Samples (1 μL) were injected in splitless mode (50 °C, 0 min; 2 °C/min; 285 °C, 20 min); helium was the carrier gas at a flow rate 1 mL/min. The database used for comparison of the results was NIST-MS version 1.7a.

4.6. Ex Vivo Pharmacological Evaluation

4.6.1. Chemicals and Drugs

Carbamoyl-choline (carbachol: CCH), norepinephrine: HCl (NE), and nifedipine were purchased from Sigma-Aldrich Co., Ltd. (St. Louis, MO, USA). All other reagents were analytical grade from local sources. Stock solutions of extracts were prepared with distilled water on the same day of experimentation.

4.6.2. Animals

Adult male Wistar rats (250–300 g bodyweight) were obtained from the Animal House of Universidad Juarez Autónoma de Tabasco (UJAT), Mexico. Animals were housed in polycarbonate cages and maintained under standard laboratory conditions (12-h light/dark cycle, at a temperature of 25 ± 2 °C, and with a humidity of 45–65%) and were fed with standard rodent diet and water ad libitum. All animal procedures were conducted in accordance with our Federal Regulations for Animal Experimentation and Care (SADER, NOM-062-ZOO-1999, México) and approved by the Institutional Animal Care and Use Committee (Register: CEBN/13/2018). All experiments were carried out using six animals per group. All study animals were sacrificed by cervical dislocation after deep anesthesia with ether.

4.6.3. General Procedures

Rats were sacrificed by cervical dislocation after deep anesthesia, and aorta tissue dissection was carried out to remove the thoracic aorta. This was cleaned from adjacent and connective nerves and then cut into rings of 3 mm in length. In addition, for some aortic rings, the endothelium layer was gently removed by manual procedures. Then, the tissue sections were assembled using stainless steel hooks under an optimal tension of 3 g. After, tissues were allowed to stabilize for 20 min at 37 °C in Krebs–Henseleit physiological solution (KHS; composition in mM: NaCl, 118; KCl, 4.7; KH2PO4, 1.2; MgSO4:H2O, 1.2; CaCl2 H2O, 2.5; NaHCO3, 25; EDTA, 0.026, and glucose, 11.1; pH, 7.4) constantly bubbled with an O2:CO2 (95:5) mixture. Tension changes were recorded by Grass-FT03 force transducers (Astro Med, West Warwick, RI, USA) connected to an MP150 analyzer (BIOPAC 4.1 Instruments, Santa Barbara, CA, USA) as described previously by Sánchez-Recillas et al., 2019 [23].

4.6.4. Vasorelaxant Activity

After the stabilization period, each aorta ring was stimulated with norepinephrine (NE [0.1 μM]) for 15 min, then washed with fresh KHS, and allowed to stabilize for 15 min. This procedure was repeated thrice. The absence of functional endothelium was confirmed by the lack (>50%) of the relaxant response induced by carbachol (CCH [1 μM]) in the last contraction with NE prior to washing with fresh KHS to assess viability.
When contraction reached a plateau, S. triquetra extracts (0.0011 to 100 μg/mL), vehicle (100% of DMSO; maximum concentration), and positive controls (CCH; a cholinergic antagonist: 6.28 × 10−4 to 1.83 μg/mL or nifedipine: a calcium channel blocker: 3.89 × 10−5 to 3.46 μg/mL) were added to the bath in cumulative concentrations. Then, concentration-response curves were obtained.

4.7. Data Analysis

The vasorelaxant activity of extracts and positive controls were determined by comparing the muscular tone of the contraction before and after the application of the test materials. The muscular tone was calculated from the tracings using Acknowledge 4.1 software. Concentration-response curves were plotted and fitted with Origin Lab version 8.0 software (Microcal®, Northampton, MA, USA).

Statistics

The ex vivo model experimental results were expressed as mean ± S.E.M of six experiments. Statistical analysis was done by two-way analysis of variance (ANOVA) with the Bonferroni test using the Origin software. p value less than 0.05 was considered statistically significant.

5. Conclusions

The results show that the hydroalcoholic extract of S. triquetra has a concentration-dependent and endothelium-dependent vasorelaxant effect, and in addition, UA was identified as one of the major compounds of the extract. There are several reports of the vasorelaxant effect of the UA in an endothelium-dependent manner and its possible mechanisms of action involving nitric oxide release in functional experiments [20,24,25]. Therefore, we can conclude that part of the vasorelaxant effect observed in all extracts may be due to UA and the additive effect of allantoin [21], which we can observe is one of the major compounds present in chromatographic analysis with a major intensity for all samples, without ruling out the future evaluation of the other compounds in the elucidation process isolated from the extract.
To our knowledge, this is the first pharmacological report regarding the vasorelaxant effect of this plant and of the compounds reported in this work that may be linked to its traditional use for chronic kidney disease complications. This is one of the most common conditions leading to secondary hypertension due to a range of causes, such as sodium retention with volume overload, renin angiotensin aldosterone axis activation, increased activity of the sympathetic nervous system, and decreased production of endogenous endothelial vasodilators, all of which are countered by the plant’s consumption [26,27]. Many reports of the renoprotective effects of UA have been described via oxidative stress, inflammation, and inhibition of the activities of the signal transducer and activator of transcription (STAT)3/nuclear factor (NF)-κB signaling pathway. Previous studies demonstrated that pre-treatment with UA significantly increased renal functioning and attenuated increases in serum angiotensin II levels in rats [28]; thus, it could be linked to the ex vivo experiments findings and the traditional use of this plant.
Many analytical methods for identification or quantification can be used for quality control purposes, such as gas chromatography with flame ionization detector (GC-FID), gas chromatography mass spectrometry (GC-MS), non-aqueous capillary electrophoresis (NACE), high-performance liquid chromatography with UV (HPLC-UV) and with diode array detector (HPLC-DAD), high-performance thin layer chromatography (HPTLC), and high-performance liquid chromatography–diode array detector–tandem mass spectrometry (UPLC-DAD-MS/MS). The implementation of techniques by UPLC-MS has become popular in recent years due to known advantages such as high sensitivity, fastness, and extensive applications. Furthermore, MS analysis provides more structural information on the chemical profile than the conventional chromatographic coupled to light detectors (HPLC-UV or HPLC-DAD), allowing for more confident identification. For quantitative MS analysis, the method of choice relies on tandem systems, mainly composed of triple quadrupole detectors, since higher sensitivity is achieved by monitoring specific ion transitions (the so-called multiple reaction monitoring MRM) [29,30]. This approach has been successfully applied in many quality control applications. Alternatively, it is possible to filter the m/z from a target ion by a single MS detector. Indeed, this method, known as SIM (selected ion monitoring), is not as sensitive as MRM, however, its cost-benefit has positioned it as a technique with potential for many purposes. Sensitivity, fastness, and broad applications [31]. With these results, we demonstrate that our method, developed for targeted ion identification, allows a rapid, sensitive, and reliable tool implementation for quality control of herbal products when previously, a full chemical and botanical identification has been required.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/ph15101289/s1, Figure S1–S34 the supplementary material for for HESt-3, HESt-1, HESt-2 [32,33,34].

Author Contributions

Methodology, A.B.A.-G., G.Y.-I. and A.S.-R.; formal analysis, M.E.C.-M., R.O.-A., A.B.A.-G. and G.Á.-V.; investigation, G.Y.-I., Y.A.-V. and J.-G.R.-C.; writing—original draft preparation, G.Á.-V., A.B.A.-G. and I.-M.M.-D.; writing—review and editing, P.G.-I.; funding acquisition, G.Á.-V. and I.-M.M.-D. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by “Programa de fortalecimiento a la Investigación UAN” [UAN-SIP18-158/ UAN-SIP17-102] and PRODEP.

Institutional Review Board Statement

The study was approved by the Institutional Ethics Committee of the State of Nayarit, Mexico (registry number CEBN/13/2018).

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contained within the article and Supplementary Material.

Acknowledgments

Author G.Á.-V. dedicates this project to the memory of Virgina Jaureguí-Medina, who inspired this work. The present work is part of the project “Preliminary scientific validation of native medicinal plants of the state of Nayarit, SIP17-102” benefited from the special tax of 12% destined for the UAN, through the convocation “University productivity through research”. Author G.Á.-V. is thankful to Giorgis Isaac for all his technical assistance with LC-MS data and English language editing. We thank QFB. Candy Montaño-Pérez and QFB. Shirley Aragón Castillo for technical support, and Jose Ricardo Medina Herrera and Ana María Hannan Allipi for the collection and identification of the plant. The authors acknowledge the Laboratorio Nacional de Estructura de Macromoléculas (Conacyt 315896) for the spectroscopic analyses.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds are available from the authors.

References

  1. Delacroix, S.; Chokka, R.G.; Worthley, S.G. Hypertension: Pathophysiology and Treatment. J. Neurol. Neurophysiol. 2014, 5, 71–75. [Google Scholar] [CrossRef] [Green Version]
  2. Singh, S.; Shankar, R.; Singh, G.P. Prevalence and Associated Risk Factors of Hypertension: A Cross-Sectional Study in Urban Varanasi. Int. J. Hypertens. 2017, 2017, 5491838. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Townsend, R.R. Chapter 21: Pathophysiology of Hypertension in Chronic Kidney Disease. In Chronic Renal Disease, 2nd ed.; Elsevier Inc.: Amsterdam, The Netherlands, 2020; pp. 313–322. [Google Scholar] [CrossRef]
  4. Wilber, J.A.; Barrow, J.G. Hypertension-A community problem. Am. J. Med. 1972, 52, 653–663. [Google Scholar] [CrossRef]
  5. Calixto, J.B. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz. J. Med. Biol. Res. 2000, 33, 179–189. [Google Scholar] [CrossRef] [PubMed]
  6. Govindaraghavan, S.; Sucher, N.J. Quality assessment of medicinal herbs and their extracts: Criteria and prerequisites for consistent safety and efficacy of herbal medicines. Epilepsy Behav. 2015, 52 Pt B, 363–371. [Google Scholar] [CrossRef]
  7. Che, C.T.; George, V.; Ijinu, T.P.; Pushpangadan, P.; Andrae-Marobela, K. Chapter 2: Traditional Medicine. In Pharmacognosy: Fundamentals, Applications and Strategy; Elsevier Inc.: Amsterdam, The Netherlands, 2017; pp. 15–30. [Google Scholar] [CrossRef]
  8. Thorsen, R.S.; Pouliot, M. Traditional medicine for the rich and knowledgeable: Challenging assumptions about treatment-seeking behaviour in rural and peri-urban Nepal. Health Policy Plan 2016, 31, 314–324. [Google Scholar] [CrossRef]
  9. Onder, G.; Liperoti, R. Herbal medications. JAMA 2016, 315, 1068. Available online: https://jamanetwork.com (accessed on 27 May 2022). [CrossRef] [Green Version]
  10. Déciga-Campos, M.; Rivero-Cruz, I.; Arriaga-Alba, M.; Castañeda-Corral, G.; Angeles-López, G.E.; Navarrete, A.; Mata, R. Acute toxicity and mutagenic activity of Mexican plants used in traditional medicine. J. Ethnopharmacol. 2007, 110, 334–342. [Google Scholar] [CrossRef]
  11. Hersch Martinez, P. La Farmacopea Nacional y el estatuto terapéutico de la flora en la biomedicina mexicana. Dynamis Acta Hisp. Med. Sci. Hist. Illus. 2001, 21, 375–407. [Google Scholar]
  12. Luna-Vázquez, F.J.; Ibarra-Alvarado, C.; Del Rayo Camacho-Corona, M.; Rojas-Molina, A.; Rojas-Molina, J.I.; García, A.; Bah, M. Vasodilator activity of compounds isolated from plants used in Mexican traditional medicine. Molecules 2018, 23, 1474. [Google Scholar] [CrossRef] [Green Version]
  13. Schifter Aceves, L. La Farmacopea mexicana. Guardiana de un patrimonio nacional viviente. Casa Del Tiempo 2010, 63–67. [Google Scholar]
  14. Rodríguez, R.H.; Pinto, A.C. Constituintes Químicos e Propriedades Biológicas de Espécies do Gênero Serjania. Rev. Virtual Quim. 2014, 6, 1583–1606. [Google Scholar]
  15. Biblioteca Digital de la Medicina Tradicional Mexicana. Bejuco de Tres Costillas [Internet]. Atlas de las Plantas de la Medicina Tradicional Mexicana. 2009. Available online: http://www.medicinatradicionalmexicana.unam.mx/monografia.php?l=3&t=&id=7294 (accessed on 2 November 2018).
  16. Chávez, M.I.; Delgado, G. Isolation and relay synthesis of 11α-hydroperoxy diacetyl hederagenin, a novel triterpenoid derivative from Serjania triquetra (Sapindaceae). Biogenetic implications. Tetrahedron 1994, 50, 3869–3878. [Google Scholar] [CrossRef]
  17. Claeson, P. Requirements on efficacy of herbal medicinal products. J. Ethnopharmacol. 2014, 158 Pt B, 463–466. [Google Scholar] [CrossRef]
  18. Pferschy-Wenzig, E.M.; Bauer, R. The relevance of pharmacognosy in pharmacological research on herbal medicinal products. Epilepsy Behav. 2015, 52, 344–362. [Google Scholar] [CrossRef]
  19. MacGregor, G.A. Diseases of the urinary system. High blood pressure and renal disease. Br. Med. J. 1977, 2, 624–626. [Google Scholar] [CrossRef] [Green Version]
  20. Somova, L.O.; Nadar, A.; Rammanan, P.; Shode, F.O. Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension. Phytomedicine 2003, 10, 115–121. [Google Scholar] [CrossRef]
  21. Chen, M.F.; Tsai, J.T.; Chen, L.J.; Wu, T.P.; Yang, J.J.; Yin, L.T.; Yang, Y.L.; Chiang, T.A.; Lu, H.L.; Wu, M.C. Antihypertensive action of allantoin in animals. Biomed Res. Int. 2014, 2014, 690135. [Google Scholar] [CrossRef]
  22. Rasheed, A.N.; Afifi, F.U.; Shaedah, M.; Taha, M.O. Investigation of the active constituents of Portulaca oleraceae L. (Portulacaceae) growing in Jordan. Pak. J. Pharm. Sci. 2004, 17, 37–45. [Google Scholar]
  23. Sánchez-Recillas, A.; González-Rivero, N.; Barrera-Canto, V.; Ibarra-Barajas, M.; Estrada-Soto, S.; Ortiz-Andrade, R. Vasorelaxant and Antihypertensive Activities of Citroflavonoids (Hesperidin/Naringenin Mixture): Potential Prophylactic of Cardiovascular Endothelial Dysfunction. Pharmacogn. Mag. 2019, 15, 84–91. [Google Scholar]
  24. Ríos, M.Y.; López-Martínez, S.; López-Vallejo, F.; Medina-Franco, J.L.; Villalobos-Molina, V.; Ibarra-Barajas, M.; Navarrete-Vázquez, G.; Hidalgo-Figueroa, S.; Hernández-Abreu, O.; Estrada-Soto, S. Vasorelaxant activity of some structurally related triterpenic acids from Phoradendron reichnbachianum (Viscaceae) mainly by NO production: Ex vivo and in silico studies. Fitoterapia 2012, 83, 1023–1029. [Google Scholar] [CrossRef] [PubMed]
  25. Estrada, O.; González-Guzmán, J.M.; Salazar-Bookaman, M.; Fernández, A.Z.; Cardozo, A.; Alvarado-Castillo, C. Pomolic acid of Licania pittieri elicits endothelium-dependent relaxation in rat aortic rings. Phytomedicine 2011, 18, 464–469. [Google Scholar] [CrossRef] [PubMed]
  26. Ghelani, H.S.; Patel, B.M.; Gokani, R.H.; Rachchh, M.A. Evaluation of polyherbal formulation (SJT-HT-03) for antihypertensive activity in albino rats. Ayu 2014, 35, 452–457. [Google Scholar] [CrossRef] [PubMed]
  27. Romanezi da Silveira, R.; Foglio, M.A.; Gontijo, J.A. Effect of the crude extract of Vernonia polyanthes Less. on blood pressure and renal sodium excretion in unanesthetized rats. Phytomedicine 2003, 10, 127–131. [Google Scholar] [CrossRef] [PubMed]
  28. Peng, J.; Ren, X.; Lan, T.; Chen, Y.; Shao, Z.; Yang, C. Renoprotective effects of ursolic acid on ischemia/reperfusion-induced acute kidney injury through oxidative stress, inflammation and the inhibition of STAT3 and NF-κB activities. Mol. Med. Rep. 2016, 14, 3397–3402. [Google Scholar] [CrossRef] [Green Version]
  29. de Paiva, J.R.; Souza, A.S.Q.; Pereira, R.C.A.; Ribeiro, P.R.V.; Zocolo, G.J.; de Brito, E.S.; Pessoa, O.D.L.; Canuto, K.M. Development and Validation of a UPLC-ESI-MS Method for Quantitation of the Anti-Alzheimer Drug Galantamine and other Amaryllidaceae Alkaloids in Plants. J. Braz. Chem. Soc. 2020, 31, 265–272. [Google Scholar] [CrossRef]
  30. Zhang, Q.; Shi, Y.; Ma, L.; Yi, X.; Ruan, J. Metabolomic Analysis Using Ultra-Performance Liquid Chromatography-Quadrupole-Time of Flight Mass Spectrometry (UPLC-Q-TOF MS) Uncovers the Effects of Light Intensity and Temperature under Shading Treatments on the Metabolites in Tea. PLoS ONE 2014, 9, e112572. [Google Scholar] [CrossRef] [Green Version]
  31. Seo, C.-S.; Song, K.-H. Phytochemical Characterization for Quality Control of Phyllostachys pubescens Leaves Using High-Performance Liquid Chromatography Coupled with Diode Array Detector and Tandem Mass Detector. Plants 2022, 11, 50. [Google Scholar] [CrossRef]
  32. Spectra Search Mass Spectrum. Available online: https://hmdb.ca/spectra/ms_ms/22586 (accessed on 22 June 2022).
  33. Spectra Search Mass Spectrum. Available online: https://hmdb.ca/spectra/ms_ms/370812 (accessed on 25 June 2022).
  34. Spectra Search Mass Spectrum. Available online: https://hmdb.ca/spectra/ms_ms/149831 (accessed on 28 June 2022).
Pharmaceuticals 15 01289 g001 550
Figure 1. Compounds identified by comparison with NIST database. Ethyl palmitate (3) (25.773%), stigmasta-3,5-dien-7-one (4) (13.927%), methyl pentacosanoate (5) (10.752%), ethyl docosanoate (6) (8.640%), ethyl oleate (7) (4.973%), stigmasta-5,22-dien-3-ol (8) (9.968%), and erucic acid (9) (1.434%).
Figure 1. Compounds identified by comparison with NIST database. Ethyl palmitate (3) (25.773%), stigmasta-3,5-dien-7-one (4) (13.927%), methyl pentacosanoate (5) (10.752%), ethyl docosanoate (6) (8.640%), ethyl oleate (7) (4.973%), stigmasta-5,22-dien-3-ol (8) (9.968%), and erucic acid (9) (1.434%).
Pharmaceuticals 15 01289 g001
Pharmaceuticals 15 01289 g002a 550Pharmaceuticals 15 01289 g002b 550Pharmaceuticals 15 01289 g002c 550
Figure 2. Fingerprinting development by UPLC-MS experiments for HESt-1, HESt-2, and HESt-3, all in negative mode (ESI-). (A) Total ion chromatogram: exploratory mass scan from 50–600 Da, the X-axis represents time, and Y-axis represents signal intensity combined with 3D Chromatogram. X-axis represents time, Y-axis represents signal intensity, and Z-axis represents mass in Da. For HESt-1, HESt-2, HESt-3, (B) SIR experiments: For identified compounds 1 allantoin 157.12 Da, 2 ethyl palmitate 283.50 Da, 3 ethyl oleate 309.50 Da, 4 erucic acid 337.60 Da, 5 ethyl docosanoate 367.60 Da, 6 methyl pentacosanoate 395.70 Da, 7 stigmasta-3,5-dien-7-one 409.70 Da, 8 stigmasta-5,22-dien-3-ol 411.70 Da, and 9 ursolic acid 455.41 Da. Further details can be found in the Supplementary Materials.
Figure 2. Fingerprinting development by UPLC-MS experiments for HESt-1, HESt-2, and HESt-3, all in negative mode (ESI-). (A) Total ion chromatogram: exploratory mass scan from 50–600 Da, the X-axis represents time, and Y-axis represents signal intensity combined with 3D Chromatogram. X-axis represents time, Y-axis represents signal intensity, and Z-axis represents mass in Da. For HESt-1, HESt-2, HESt-3, (B) SIR experiments: For identified compounds 1 allantoin 157.12 Da, 2 ethyl palmitate 283.50 Da, 3 ethyl oleate 309.50 Da, 4 erucic acid 337.60 Da, 5 ethyl docosanoate 367.60 Da, 6 methyl pentacosanoate 395.70 Da, 7 stigmasta-3,5-dien-7-one 409.70 Da, 8 stigmasta-5,22-dien-3-ol 411.70 Da, and 9 ursolic acid 455.41 Da. Further details can be found in the Supplementary Materials.
Pharmaceuticals 15 01289 g002aPharmaceuticals 15 01289 g002bPharmaceuticals 15 01289 g002c
Pharmaceuticals 15 01289 g003 550
Figure 3. The vasorelaxant effect induced by S. triquetra extracts on aortic rings pre-contracted with NE [0.1 µM]. Results are expressed as the mean ± S.E.M of six experiments. (*) Indicates significance on comparison between all extracts (p< 0.05).
Figure 3. The vasorelaxant effect induced by S. triquetra extracts on aortic rings pre-contracted with NE [0.1 µM]. Results are expressed as the mean ± S.E.M of six experiments. (*) Indicates significance on comparison between all extracts (p< 0.05).
Pharmaceuticals 15 01289 g003
Table
Table 1. Extraction yields obtained from stems of Serjania triquetra.
Table 1. Extraction yields obtained from stems of Serjania triquetra.
CodeDry Material (g)Extract %Description
HESt-185014.21Freshly collected material
HESt-25006.63Herbal remedy bulk marketed
HESt-32109.84Tea marketed in cellophane bags
Table
Table 2. 1H and 13C NMR chemical shifts (δ, ppm) of allantoin in DMSO-d6.
Table 2. 1H and 13C NMR chemical shifts (δ, ppm) of allantoin in DMSO-d6.
Positionδ Cδ H
1-10.58
2157.3-
3-6.91
462.908.07
5174.0
6-5.23
7157.90
8 5.81
Table
Table 3. Chemical composition of groups 1 and 5 obtained from OCC fractionation of the hydroalcoholic extract of S. triquetra.
Table 3. Chemical composition of groups 1 and 5 obtained from OCC fractionation of the hydroalcoholic extract of S. triquetra.
CompoundGroupRT †RI aRI bCompound NameEssential Oil (%)
3165.59219591975Ethyl palmitate25.773
41115.65233112718Stigmasta-3,5-dien-7-one13.927
5197.54227452822Methyl pentacosanoate10.752
6190.41525492576Ethyl docosanoate8.640
7173.22521262175Ethyl oleate4.973
85111.38931693248Stigmasta-5,22-dien-3-ol9.968
9578.74322542546Erucic acid1.434
RT † Retention time in minutes; RI a calculated, retention indices; RI b reported.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Aguilar-Guadarrama, A.B.; Yáñez-Ibarra, G.; Cancino-Marentes, M.E.; González-Ibarra, P.; Ortiz-Andrade, R.; Sánchez-Recillas, A.; Rodríguez-Carpena, J.-G.; Aguirre-Vidal, Y.; Medina-Diaz, I.-M.; Ávila-Villarreal, G. Chromatographic Techniques and Pharmacological Analysis as a Quality Control Strategy for Serjania triquetra a Traditional Medicinal Plant. Pharmaceuticals 2022, 15, 1289. https://doi.org/10.3390/ph15101289

AMA Style

Aguilar-Guadarrama AB, Yáñez-Ibarra G, Cancino-Marentes ME, González-Ibarra P, Ortiz-Andrade R, Sánchez-Recillas A, Rodríguez-Carpena J-G, Aguirre-Vidal Y, Medina-Diaz I-M, Ávila-Villarreal G. Chromatographic Techniques and Pharmacological Analysis as a Quality Control Strategy for Serjania triquetra a Traditional Medicinal Plant. Pharmaceuticals. 2022; 15(10):1289. https://doi.org/10.3390/ph15101289

Chicago/Turabian Style

Aguilar-Guadarrama, A. Berenice, Guadalupe Yáñez-Ibarra, Martha Edith Cancino-Marentes, Paola González-Ibarra, Rolffy Ortiz-Andrade, Amanda Sánchez-Recillas, Javier-German Rodríguez-Carpena, Yoshajandith Aguirre-Vidal, Irma-Martha Medina-Diaz, and Gabriela Ávila-Villarreal. 2022. "Chromatographic Techniques and Pharmacological Analysis as a Quality Control Strategy for Serjania triquetra a Traditional Medicinal Plant" Pharmaceuticals 15, no. 10: 1289. https://doi.org/10.3390/ph15101289

APA Style

Aguilar-Guadarrama, A. B., Yáñez-Ibarra, G., Cancino-Marentes, M. E., González-Ibarra, P., Ortiz-Andrade, R., Sánchez-Recillas, A., Rodríguez-Carpena, J. -G., Aguirre-Vidal, Y., Medina-Diaz, I. -M., & Ávila-Villarreal, G. (2022). Chromatographic Techniques and Pharmacological Analysis as a Quality Control Strategy for Serjania triquetra a Traditional Medicinal Plant. Pharmaceuticals, 15(10), 1289. https://doi.org/10.3390/ph15101289

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop